You see a filtered list - Keywords: Berres-Selection
[1]B. Hogstad, M. Berres, R. Chakraborty, J. Tang, C. Bigenwald, M. Serasinghe, K. P. H. Lim, H. Lin, T. Man, R. Remark, S. Baxter, V. Kana, S. Jordan, Z. Karoulia, W. Kwan, M. Leboeuf, E. Brandt, H. Salmon, K. McClain, P. Poulikakos, J. Chipuk, W. J. M. Mulder, C. E. Allen, M. Merad,
"RAF/MEK/extracellular signal-related kinase pathway suppresses dendritic cell migration and traps dendritic cells in Langerhans cell histiocytosis lesions", Journal of experimental medicine, vol. 215, no. 1, 2018, pp. 319–336.
[bibtex] [url] [doi]
[2]M. Berres, S. Asmacher, J. Lehmann, C. Jansen, J. Görtzen, S. Klein, C. Meyer, H. M. Strunk, R. Fimmers, F. Tacke, C. P. Strassburg, C. Trautwein, T. Sauerbruch, H. E. Wasmuth, J. Trebicka,
"CXCL9 is a prognostic marker in patients with liver cirrhosis receiving transjugular intrahepatic portosystemic shunt", Journal of hepatology, vol. 62, no. 2, 2015, pp. 332–339.
[bibtex] [url] [doi]
[3]M. Berres, J. Lehmann, C. Jansen, J. Görtzen, C. Meyer, D. Thomas, H. W. Zimmermann, D. Kroy, F. Schumacher, C. P. Strassburg, T. Sauerbruch, C. Trautwein, H. E. Wasmuth, J. Trebicka,
"Chemokine (C-X-C motif) ligand 11 levels predict survival in cirrhotic patients with transjugular intrahepatic portosystemic shunt", Liver International, vol. 36, no. 3, 2015, pp. 386–394.
[bibtex] [url] [doi]
[4]P. A. Muller, B. Koscs{ó}, G. M. Rajani, K. Stevanovic, M. Berres, D. Hashimoto, A. Mortha, M. Leboeuf, X. Li, D. Mucida, E. R. Stanley, S. Dahan, K. G. Margolis, M. D. Gershon, M. Merad, M. Bogunovic,
"Crosstalk between Muscularis Macrophages and Enteric Neurons Regulates Gastrointestinal Motility", Cell, vol. 158, no. 2, 2014, pp. 300–313.
[bibtex] [url] [doi]
[5]D. Heinrichs, M. Berres, M. Coeuru, M. Knauel, A. Nellen, P. Fischer, C. Philippeit, R. Bucala, C. Trautwein, H. E. Wasmuth, J. Bernhagen,
"Protective role of macrophage migration inhibitory factor in nonalcoholic steatohepatitis", The FASEB journal, vol. 28, no. 12, 2014, pp. 5136–5147.
[bibtex] [url] [doi]
[6]M. Berres, K. P. H. Lim, T. Peters, J. Price, H. Takizawa, H. Salmon, J. Idoyaga, A. Ruzo, P. J. Lupo, M. J. Hicks, A. Shih, S. J. Simko, H. Abhyankar, R. Chakraborty, M. Leboeuf, M. Beltrão, S. A. Lira, K. M. Heym, B. E. Clausen, V. Bigley, M. Collin, M. G. Manz, K. McClain, M. Merad, C. E. Allen,
"BRAF-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups", Journal of experimental medicine, vol. 211, no. 4, 2014, pp. 669–683.
[bibtex] [url] [doi]
[7]M. Berres, B. Schlösser, T. Berg, C. Trautwein, H. E. Wasmuth,
"Soluble Urokinase Plasminogen Activator Receptor is Associated With Progressive Liver Fibrosis in Hepatitis C Infection", Journal of clinical gastroenterology, vol. 46, no. 4, 2012, pp. 334–338.
[bibtex] [url] [doi]
[8]M. Berres, C. Trautwein, M. Schmeding, D. Eurich, F. Tacke, M. Bahra, P. Neuhaus, U. P. Neumann, H. E. Wasmuth,
"Serum chemokine CXC ligand 10 (CXCL10) predicts fibrosis progression after liver transplantation for hepatitis C infection", Hepatology, vol. 53, no. 2, 2011, pp. 596–603.
[bibtex] [url] [doi]
[9]M. Berres, R. R. Koenen, A. Rueland, M. Moreno Zaldivar, D. Heinrichs, H. Sahin, P. Schmitz, K. L. Streetz, T. Berg, N. Gaßler, R. Weiskirchen, A. E. Proudfoot, C. Weber, C. Trautwein, H. E. Wasmuth,
"Antagonism of the chemokine Ccl5 ameliorates experimental liver fibrosis in mice", The journal of clinical investigation, vol. 120, no. 11, 2010, pp. 4129–4140.
[bibtex] [url] [doi]
[10]M. Berres, S. Papen, K. Pauels, P. Schmitz, M. Moreno Zaldivar, C. Hellerbrand, T. Mueller, T. Berg, R. Weiskirchen, C. Trautwein, H. E. Wasmuth,
"A functional variation in CHI3L1 is associated with severity of liver fibrosis and YKL-40 serum levels in chronic hepatitis C infection", Journal of hepatology, vol. 50, no. 2, 2009, pp. 370–376.
[bibtex] [url] [doi]